Xenon Pharmaceuticals (XENE) Shares Issued (2013 - 2026)

Xenon Pharmaceuticals (XENE) has 14 years of Shares Issued data on file, last reported at $5.7 million in Q1 2026.

• On a quarterly basis, Shares Issued fell 13.18% year-over-year to $5.7 million in Q1 2026; TTM through Mar 2026 was $5.7 million, a 13.18% decrease from a year earlier, with the FY2025 full-year figure at $11.1 million, up 3.41% from the prior year.
• Shares Issued for Q1 2026 stood at $5.7 million, down from $11.1 million in the prior quarter.
• Over the last five years, Shares Issued for XENE reached as high as $11.2 million in Q3 2025 and fell as low as $3.4 million in Q3 2022.
• Historically, Shares Issued has averaged $7.6 million across 5 years, with a median of $7.1 million in 2022.
• Across the five-year window, Shares Issued plunged 42.71% in 2022 and surged 160.18% in 2024, its largest moves.
• Year by year, Shares Issued stood at $7.1 million in 2022, then rose by 24.96% to $8.9 million in 2023, then advanced by 20.4% to $10.7 million in 2024, then increased by 3.41% to $11.1 million in 2025, then sank by 48.67% to $5.7 million in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $5.7 million in Q1 2026, $11.1 million in Q4 2025, and $11.2 million in Q3 2025.